S&P 500   3,971.27 (-0.16%)
DOW   32,394.25 (-0.12%)
QQQ   307.12 (-0.53%)
AAPL   157.65 (-0.40%)
MSFT   275.23 (-0.42%)
META   200.68 (-1.06%)
GOOGL   101.03 (-1.40%)
AMZN   97.24 (-0.82%)
TSLA   189.19 (-1.37%)
NVDA   264.10 (-0.46%)
NIO   9.20 (+3.02%)
BABA   98.40 (+14.26%)
AMD   94.56 (-2.12%)
T   18.72 (-0.79%)
F   11.60 (+0.69%)
MU   59.28 (-0.85%)
CGC   1.81 (-3.72%)
GE   93.14 (-0.18%)
DIS   94.82 (-0.84%)
AMC   5.15 (+13.19%)
PYPL   72.70 (-0.82%)
PFE   39.99 (-0.57%)
NFLX   323.52 (-1.26%)
S&P 500   3,971.27 (-0.16%)
DOW   32,394.25 (-0.12%)
QQQ   307.12 (-0.53%)
AAPL   157.65 (-0.40%)
MSFT   275.23 (-0.42%)
META   200.68 (-1.06%)
GOOGL   101.03 (-1.40%)
AMZN   97.24 (-0.82%)
TSLA   189.19 (-1.37%)
NVDA   264.10 (-0.46%)
NIO   9.20 (+3.02%)
BABA   98.40 (+14.26%)
AMD   94.56 (-2.12%)
T   18.72 (-0.79%)
F   11.60 (+0.69%)
MU   59.28 (-0.85%)
CGC   1.81 (-3.72%)
GE   93.14 (-0.18%)
DIS   94.82 (-0.84%)
AMC   5.15 (+13.19%)
PYPL   72.70 (-0.82%)
PFE   39.99 (-0.57%)
NFLX   323.52 (-1.26%)
S&P 500   3,971.27 (-0.16%)
DOW   32,394.25 (-0.12%)
QQQ   307.12 (-0.53%)
AAPL   157.65 (-0.40%)
MSFT   275.23 (-0.42%)
META   200.68 (-1.06%)
GOOGL   101.03 (-1.40%)
AMZN   97.24 (-0.82%)
TSLA   189.19 (-1.37%)
NVDA   264.10 (-0.46%)
NIO   9.20 (+3.02%)
BABA   98.40 (+14.26%)
AMD   94.56 (-2.12%)
T   18.72 (-0.79%)
F   11.60 (+0.69%)
MU   59.28 (-0.85%)
CGC   1.81 (-3.72%)
GE   93.14 (-0.18%)
DIS   94.82 (-0.84%)
AMC   5.15 (+13.19%)
PYPL   72.70 (-0.82%)
PFE   39.99 (-0.57%)
NFLX   323.52 (-1.26%)
S&P 500   3,971.27 (-0.16%)
DOW   32,394.25 (-0.12%)
QQQ   307.12 (-0.53%)
AAPL   157.65 (-0.40%)
MSFT   275.23 (-0.42%)
META   200.68 (-1.06%)
GOOGL   101.03 (-1.40%)
AMZN   97.24 (-0.82%)
TSLA   189.19 (-1.37%)
NVDA   264.10 (-0.46%)
NIO   9.20 (+3.02%)
BABA   98.40 (+14.26%)
AMD   94.56 (-2.12%)
T   18.72 (-0.79%)
F   11.60 (+0.69%)
MU   59.28 (-0.85%)
CGC   1.81 (-3.72%)
GE   93.14 (-0.18%)
DIS   94.82 (-0.84%)
AMC   5.15 (+13.19%)
PYPL   72.70 (-0.82%)
PFE   39.99 (-0.57%)
NFLX   323.52 (-1.26%)
NASDAQ:JAZZ

Jazz Pharmaceuticals - JAZZ Short Interest Ratio & Short Volume

$142.60
-0.75 (-0.52%)
(As of 03/28/2023 04:00 PM ET)
Add
Compare
Today's Range
$142.54
$144.40
50-Day Range
$133.98
$157.77
52-Week Range
$125.36
$169.98
Volume
407,570 shs
Average Volume
534,956 shs
Market Capitalization
$9.03 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$204.27

Jazz Pharmaceuticals Short Interest Data

Current Short Volume
2,320,000 shares
Previous Short Volume
2,440,000 shares
Change Vs. Previous Month
-4.92%
Dollar Volume Sold Short
$312.94 million
Short Interest Ratio / Days to Cover
4.4
Last Record Date
March 15, 2023
Outstanding Shares
63,330,000 shares
Percentage of Shares Shorted
3.66%
Today's Trading Volume
407,570 shares
Average Trading Volume
534,956 shares
Today's Volume Vs. Average
-23.81%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Jazz Pharmaceuticals ?

Sign up to receive the latest short interest report for Jazz Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

JAZZ Short Interest Over Time

JAZZ Days to Cover Over Time

JAZZ Percentage of Float Shorted Over Time

Jazz Pharmaceuticals (NASDAQ:JAZZ) Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
3/15/20232,320,000 shares $312.94 million -4.9%N/A4.4 $134.89
2/28/20232,440,000 shares $342.58 million -1.6%N/A4.2 $140.40
2/15/20232,480,000 shares $370.54 million -3.9%N/A4.6 $149.41
1/31/20232,580,000 shares $404.18 million -1.9%N/A4.6 $156.66
1/15/20232,630,000 shares $411.52 million -2.6%N/A4.8 $156.47
12/30/20222,700,000 shares $430.14 million +21.1%N/A5 $159.31
12/15/20222,230,000 shares $341.10 million +2.8%N/A4 $152.96
11/30/20222,170,000 shares $340.49 million -7.7%N/A4 $156.91
11/15/20222,350,000 shares $348.83 million -1.7%N/A4.5 $148.44
10/31/20222,390,000 shares $343.66 million +6.2%N/A4.7 $143.79
10/15/20222,250,000 shares $299.72 million -14.1%N/A4.3 $133.21
9/30/20222,620,000 shares $349.22 million -4.4%N/A5 $133.29
9/15/20222,740,000 shares $416.97 million -1.4%N/A5.3 $152.18
8/31/20222,780,000 shares $431.51 million No ChangeN/A5.7 $155.22
8/15/20222,780,000 shares $445.52 million +3.0%N/A5.4 $160.26
7/31/20222,700,000 shares $421.36 million -9.7%4.5%5.2 $156.06
7/15/20222,990,000 shares $470.75 million +2.8%4.9%5.8 $157.44
6/30/20222,910,000 shares $453.99 million -4.9%4.8%5.4 $156.01
6/15/20223,060,000 shares $446.09 million -13.8%5.1%5.5 $145.78
5/31/20223,550,000 shares $531.36 million +10.6%5.9%6.7 $149.68
5/15/20223,210,000 shares $470.23 million -2.7%5.3%5.5 $146.49
4/30/20223,300,000 shares $528.73 million -12.2%5.6%5.6 $160.22
4/15/20223,760,000 shares $628.86 million +4.7%6.3%6.6 $167.25
3/31/20223,590,000 shares $558.86 million -5.0%6.0%5.7 $155.67
3/15/20223,780,000 shares $584.88 million -6.9%6.3%6.2 $154.73
2/28/20224,060,000 shares $557.93 million -6.0%6.8%6.4 $137.42
2/15/20224,320,000 shares $624.11 million +0.9%7.2%7 $144.47
1/31/20224,280,000 shares $594.53 million +3.9%7.2%6.9 $138.91
1/15/20224,120,000 shares $594.52 million -7.2%6.9%6.7 $144.30
12/31/20214,440,000 shares $565.66 million +0.7%7.4%7.4 $127.40
12/15/20214,410,000 shares $536.83 million +9.7%7.4%7.4 $121.73
11/30/20214,020,000 shares $481.88 million -2.7%6.7%6.4 $119.87
11/15/20214,130,000 shares $574.81 million +7.8%6.9%6.6 $139.18
10/29/20213,830,000 shares $509.54 million No Change6.4%5.8 $133.04
10/15/20213,830,000 shares $538.88 million +7.6%6.4%5.4 $140.70
9/30/20213,560,000 shares $463.55 million -1.1%6.0%5 $130.21
9/15/20213,600,000 shares $479.52 million -3.0%6.1%5.4 $133.20
8/31/20213,710,000 shares $488.64 million -12.9%6.2%5.4 $131.71
8/13/20214,260,000 shares $605.60 million +1.2%7.2%6.4 $142.16
7/30/20214,210,000 shares $713.68 million +2.2%7.1%6.5 $169.52













JAZZ Short Interest - Frequently Asked Questions

What is Jazz Pharmaceuticals' current short interest?

Short interest is the volume of Jazz Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of March 15th, investors have sold 2,320,000 shares of JAZZ short. Learn More on Jazz Pharmaceuticals' current short interest.

What is a good short interest ratio for Jazz Pharmaceuticals?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. JAZZ shares currently have a short interest ratio of 4.0. Learn More on Jazz Pharmaceuticals's short interest ratio.

Which institutional investors are shorting Jazz Pharmaceuticals?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Jazz Pharmaceuticals: Jane Street Group LLC, Centiva Capital LP, Susquehanna International Group LLP, CSS LLC IL, Group One Trading L.P., Cutler Group LLC CA, Simplex Trading LLC, Wolverine Asset Management LLC, Equitec Proprietary Markets LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Is Jazz Pharmaceuticals' short interest increasing or decreasing?

Jazz Pharmaceuticals saw a decline in short interest in March. As of March 15th, there was short interest totaling 2,320,000 shares, a decline of 4.9% from the previous total of 2,440,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Jazz Pharmaceuticals' short interest compare to its competitors?

Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Jazz Pharmaceuticals: Perrigo Company plc (4.18%), Horizon Therapeutics Public Limited (1.43%), Dr. Reddy's Laboratories Limited (0.81%), Teva Pharmaceutical Industries Limited (2.30%), United Therapeutics Co. (2.87%), Apellis Pharmaceuticals, Inc. (9.65%), Legend Biotech Co. (2.88%), Viatris Inc. (1.73%), Sarepta Therapeutics, Inc. (9.18%), and Ascendis Pharma A/S (5.74%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Canadian Natural Resources Limited ($3.66 billion), Occidental Petroleum Co. ($2.62 billion), Coinbase Global, Inc. ($2.38 billion), T. Rowe Price Group, Inc. ($2.13 billion), Verisk Analytics, Inc. ($2.08 billion), Snowflake Inc. ($1.95 billion), Paramount Global ($1.78 billion), Etsy, Inc. ($1.60 billion), Teck Resources Limited ($1.51 billion), and Voya Financial, Inc. ($1.49 billion). View all of the most shorted stocks.

What does it mean to sell short Jazz Pharmaceuticals stock?

Short selling JAZZ is an investing strategy that aims to generate trading profit from Jazz Pharmaceuticals as its price is falling. JAZZ shares are trading down $0.75 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Jazz Pharmaceuticals?

A short squeeze for Jazz Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of JAZZ, which in turn drives the price of the stock up even further.

How often is Jazz Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including JAZZ, twice per month. The most recent reporting period available is March, 15 2023.



This page (NASDAQ:JAZZ) was last updated on 3/28/2023 by MarketBeat.com Staff